Chinese drug maker Wuxi AppTec’s upbeat business update boosts stock despite US bill

Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.

A presentation persuaded investors that risk of a potential US blacklisting is low while growth in some business areas is ‘unprecedented’.